Skip to main content
Perseus Proteomics Inc. logo

Perseus Proteomics Inc. — Investor Relations & Filings

Ticker · 4882 ISIN · JP3836800007 T Professional, scientific and technical activities
Open in API
Filings indexed 56 across all filing types
Latest filing 2022-06-23 Governance Information
Country JP Japan
Listing T 4882

About Perseus Proteomics Inc.

https://www.ppmx.com/en/

Perseus Proteomics Inc. is a drug discovery biotechnology company specializing in the development of novel antibody-based therapeutics and diagnostics. Originating from the University of Tokyo, the company leverages proprietary antibody technologies and screening platforms to create a pipeline of drug candidates targeting cancer and other diseases. Its business is structured into three main segments: Drug Discovery, which focuses on its internal pipeline; Antibody Research Support, offering services to the research community; and Antibody/Reagent Sales, which provides products like ELISA kits. The company aims to contribute to global healthcare through its advanced antibody-based solutions.

Recent filings

Filing Released Lang Actions
内部統制報告書－第22期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. This type of regulatory filing, which is a standalone report on internal control systems rather than a full annual report or a simple announcement, falls under the 'Regulatory Filings' category as it does not fit into the more specific categories like 10-K or AR (which typically refers to external audit reports on financial statements).
2022-06-23 Japanese
確認書
Audit Report / Information Classification · 98% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory internal control certification that accompanies the Annual Securities Report (Yuho). Since the document is a specific regulatory filing required to certify the accuracy of the annual report rather than the annual report itself, and it does not fit into the other specific categories like 'Annual Report' (10-K) or 'Report Publication Announcement' (RPA), it is classified as a Regulatory Filing. FY 2022
2022-06-23 Japanese
有価証券報告書－第22期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) filed with the Kanto Local Finance Bureau in Japan. It covers the fiscal year from April 1, 2021, to March 31, 2022, for Perseus Proteomics Inc. It contains comprehensive financial data, management discussion, and corporate information, which corresponds to the definition of an Annual Report (10-K) in the provided schema. FY 2022
2022-06-23 Japanese
四半期報告書－第22期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements (balance sheet, income statement) for the third quarter of the fiscal year ending 2021-12-31. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report (IR). 9M 2022
2022-02-14 Japanese
四半期報告書－第22期第2四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements (balance sheets, etc.) and management analysis for the second quarter of the 22nd fiscal period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2022
2021-11-12 Japanese
四半期報告書－第22期第1四半期(令和3年4月1日－令和3年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements (balance sheet, income statement) for the first quarter of the 22nd fiscal period (April 1, 2021, to June 30, 2021). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report (IR). Q1 2022
2021-08-13 Japanese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.